Abstract
No public abstract is available from the verified source records.
Gilbert Mchantaf, Laurence Morand-Joubert, Antoine Cheret, Laurent Hocqueloux, Véronique Avettand-Fenoel
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance
10.1093/cid/ciaf161 · 2025
Unresolved referenced work
Kept as external metadata until matched
Clearance of archived integrase strand transfer inhibitors resistance mutations in people with virologically suppressed HIV infection
10.1093/jacamr/dlae194 · 2024
Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected Patients
10.1093/infdis/jiab413 · 2022
The RT M184V resistance mutation clearance in the reservoir is mainly related to CD4 nadir and viral load zenith independently of therapeutic regimen type
10.1093/jac/dkae164 · 2024
Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial
10.1016/s1473-3099(24)00289-5 · 2024
Randomized Trial of Long-Acting Cabotegravir and Rilpivirine in Africa (CARES): Week 96 Results
2025
Kinetics of Non-nucleoside Reverse Transcriptase Inhibitor Resistance-associated Mutations in HIV-1 Proviral Cellular Reservoirs in Non-nucleoside Reverse Transcriptase Inhibitor-experienced Persons
datacite
Confidence 0%
10.1093/cid/ciaf430 · 2026
Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients
10.1089/apc.2019.0198 · 2020
Use of genotypic HIV DNA testing: a DELPHI-type consensus
10.1093/jac/dkae007 · 2024
No virological failure in patients living with HIV with past NNRTI resistance-associated mutations switched to doravirine-containing regimens
10.1093/jac/dkae481 · 2025
Learning From Full Characterization of HIV Proviruses in People Receiving Long-Acting Cabotegravir/Rilpivirine With a History of Replication on the Antiretroviral Classes
2025
Fully injectable antiretroviral multitherapy to overcome decades of virological failure in three women with hiv-1 and non-adherent to oral drugs
10.1016/j.ijantimicag.2024.107254 · 2024
Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons With Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results of a Single-Arm, Open-Label, Multicenter, Phase IIa Clinical Trial
10.1093/cid/ciaf100 · 2025
Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants
10.1016/j.celrep.2017.09.081 · 2017
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure
10.1016/j.cell.2013.09.020 · 2013
In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control
10.1128/spectrum.03267-22 · 2023
Unresolved referenced work
Kept as external metadata until matched
Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review
10.3390/v15091932 · 2023
Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals
10.1016/j.jcv.2023.105551 · 2023
Defective HIV-1 quasispecies in the form of multiply drug-resistant proviral DNA within cells can be rescued by superinfection with different subtype variants of HIV-1 and by HIV-2 and SIV
10.1093/jac/dkt326 · 2014
Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants
10.1086/606117 · 2009
Superinfection promotes replication and diversification of defective HIV-1 proviruses in people with non-suppressible viraemia
10.1038/s41564-025-02135-z · 2025
Unresolved referenced work
Kept as external metadata until matched
Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing
10.1093/jac/dkt316 · 2014
Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy
10.1172/jci124291 · 2019
Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses
10.1016/j.cell.2021.12.011 · 2022
Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection
10.1084/jem.20241091 · 2024
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
10.1128/jvi.01920-18 · 2019
Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1
10.1073/pnas.2020617117 · 2020
Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption
10.1126/scitranslmed.abd8179 · 2021
Next-generation sequencing and drug resistance mutations of HIV-1 subtypes in people living with HIV in Sicily, Italy, 2021-2023
10.1016/j.jgar.2024.12.015 · 2024
Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications
10.1128/cmr.00015-16 · 2016
Kinetics of non-nucleoside reverse transcriptase inhibitor resistance-associated mutations in HIV-1 proviral cellular reservoirs in NNRTI-experienced persons
2025
The multifaceted nature of HIV tissue reservoirs
10.1097/coh.0000000000000851 · 2024
Eliminating HIV reservoirs for a cure: the issue is in the tissue
10.1097/coh.0000000000000688 · 2021
HIV persists throughout deep tissues with repopulation from multiple anatomical sources
10.1172/jci134815 · 2020
Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ART
10.1016/j.celrep.2023.113053 · 2023
HIV Variability in the Liver and Evidence of Possible Compartmentalization
10.1089/aid.2010.0329 · 2011
The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies
10.1016/j.chom.2020.03.014 · doi-reference
The multifaceted nature of HIV latency
10.1172/jci136227 · doi-reference
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
10.1038/nm.1972 · doi-reference
Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART
10.1038/s41467-020-17898-8 · doi-reference
Clonal Expansion of Infected CD4+ T Cells in People Living with HIV
10.3390/v13102078 · doi-reference
Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing
10.1073/pnas.2117630119 · doi-reference
Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression
10.1093/jac/dkv395 · doi-reference
HIV persistence in tissues on dolutegravir-based therapy is not associated with resistance mutations to dolutegravir
10.1038/s43856-026-01405-z · doi-reference
Compartmentalization and Clonal Amplification of HIV-1 in the Male Genital Tract Characterized Using Next-Generation Sequencing
10.1128/jvi.00229-20 · doi-reference
HIV Diversity and Genetic Compartmentalization in Blood and Testes during Suppressive Antiretroviral Therapy
10.1128/jvi.00755-19 · doi-reference
Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4+ T Cell Subsets during Long-Term Combination Antiretroviral Therapy
10.1128/jvi.01786-19 · doi-reference
Identification of HIV-1 genitourinary tract compartmentalization by analyzing the env gene sequences in urine
10.1097/qad.0000000000000757 · doi-reference